Pharma stocks drop on Trump drug price reform proposals
user-generated· price
Pharma stocks drop on Trump drug price reform proposals
Market overview
Trump's proposals to allow Medicare price negotiations and cap out-of-pocket costs will likely pressure pharmaceutical stock valuations, particularly for high-margin drugmakers. Investors may sell shares in companies like Pfizer and Merck in anticipation of lower revenue.
price prediction market
- Implied probability (Yes)
- 75%
Source: user-generated
More price markets
- Deet-based repellent sales drop by 15% in 2027 — 55% Yes
- Nvidia stock falls 15% by Nov 11 — 60% Yes
- Indonesia's local currency bond yields rise by 50bps within 3 months of downgrade announcement — 75% Yes
- Equinox Gold's stock rises 10% post-acquisition announcement — 70% Yes
- Anthropic shares surge in unapproved secondary markets — 75% Yes
- U.S. dollar index drops below 100 by July 2026 — 65% Yes
- US regional bank ETF outperforms major indices by year-end 2026 — 70% Yes
- SpaceX stock to recover 10% by year-end — 60% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…